Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith in 2010 and is headquartered in Menlo Park, CA.